• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEZ NORTH AMERICA, INC. COAPTITE INJECTABLE IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEZ NORTH AMERICA, INC. COAPTITE INJECTABLE IMPLANT Back to Search Results
Catalog Number 8005P10
Device Problem Insufficient Information (3190)
Patient Problems Urinary Tract Infection (2120); Test Result (2695)
Event Date 11/23/2011
Event Type  Other  
Event Description
A pt (b)(6) was enrolled in (b)(6) study for stress urinary incontinence.On (b)(6) 2010, the pt was injected with 2.0 ml coaptite, lot 1018370.On (b)(6) 2012, the pt developed urinary tract infection identified through urinalysis.On (b)(6) 2012, the pt was treated with antibiotic ciprofloxacin 250mg po bid.The adverse event resolved on (b)(6) 2013.Per physician, the event was of mild severity and probably not related to coaptite.On (b)(6) 2013, the pt developed urinary tract infection reported by a pt.On (b)(6) 2013, the pt was treated with an antibiotic macrobid 100 mg po q12hrs x 10m days.The adverse event resolved on (b)(6) 2013.Per physician, the event was of mild severity and probably not related to coaptite.
 
Manufacturer Narrative
At the time of this report, the urinary tract infections have resolved.The device history records for the reported lots were reviewed, all required testing specs were met prior to release, there were no abnormalities noted.
 
Manufacturer Narrative
The device history records for the reported lot were reviewed.All required testing specifications were met prior to release.There were no abnormalities noted.
 
Event Description
The patient was enrolled in the coaptite injectable implant study for stress urinary incontinence.On (b)(6) 2013 the patient was injected with 2.0 ml of copatite, lot 1035202.On (b)(6) 2011 the patient had a urinary tract infection that was diagnosed by a urinalysis.On (b)(6) 2011 the patient was prescribed keflex 250mg tid x 7 days.As of (b)(6) 2011 the event was resolved.The physician assessed the event as mild and possibly device related.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAPTITE INJECTABLE IMPLANT
Type of Device
INJECTABLE IMPLANT
Manufacturer (Section D)
MEZ NORTH AMERICA, INC.
franksville WI
Manufacturer Contact
r. stemler
4133 courtney road, ste #10
franksville, WI 53126
2628353300
MDR Report Key4223987
MDR Text Key5068866
Report Number2135225-2014-00073
Device Sequence Number1
Product Code LNM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative,company representati
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 09/29/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2015
Device Catalogue Number8005P10
Device Lot Number1035202
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 10/01/2014
Initial Date FDA Received10/29/2014
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received10/29/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/24/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age78 YR
Patient Weight70
-
-